Amylin is a natural hormone released by the pancreas alongside insulin, and it plays a big role in appetite and stomach emptying that GLP-1 drugs on their own do not target
The peptide is primarily studied for targeted lipolysis the breakdown of stored triglycerides as well as adipose tissue metabolism, body composition endpoints, and more recently chondrocyte and cartilage repair models
Its proposed action is delivering copper and signalling to dermal papilla cells , the specialised fibroblasts that drive the hair-follicle growth cycle [1]
First, SELECT was designed as a CV outcomes trial and not a weight-loss trial, and weight loss was only a supportive secondary endpoint in the trial design
However, no research directly compares continuous use versus cycling protocols (such as 12 weeks on, 4-8 weeks off), leaving optimal long-term strategies somewhat uncertain